{"title":"Change in Serum Biomarkers in Patients with Osteoarthritis treated with Collagen Hydrolysate: Results of a Prospective Randomized Study","authors":"K. Flechsenhar, T. McAlindon","doi":"10.4172/2167-7921.1000219","DOIUrl":null,"url":null,"abstract":"Klaus Flechsenhar1 and Timothy McAlindon2 1Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 2Tufts Medical Center, Chief, Division of Rheumatology, Boston, USA *Corresponding author: Klaus Flechsenhar, MD, Sanofi-Aventis Deutschland GmbH, Therapeutic Area Immunology, Cytokine Modulation, Industriepark Hoechst, Building H821, Room 525, D-65926 Frankfurt am Main Germany, Tel: +49 69 305 17403; Fax: +49 69 305 47223; E-mail: Klaus.Flechsenhar@sanofi.com","PeriodicalId":91304,"journal":{"name":"Journal of arthritis","volume":"5 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2167-7921.1000219","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of arthritis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-7921.1000219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Klaus Flechsenhar1 and Timothy McAlindon2 1Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 2Tufts Medical Center, Chief, Division of Rheumatology, Boston, USA *Corresponding author: Klaus Flechsenhar, MD, Sanofi-Aventis Deutschland GmbH, Therapeutic Area Immunology, Cytokine Modulation, Industriepark Hoechst, Building H821, Room 525, D-65926 Frankfurt am Main Germany, Tel: +49 69 305 17403; Fax: +49 69 305 47223; E-mail: Klaus.Flechsenhar@sanofi.com
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
